Shots:
- This edition explores Tailored Therapy, Smarter Decisions: AI in Personalized Medicine, highlighting how artificial intelligence, machine learning, multi-omics, real-world data, and predictive analytics are transforming personalized medicine into a more precise, data-driven, and patient-centric approach to care, enabling better patient stratification, treatment selection, and clinical decision-making.
- Through expert perspectives, feature stories, and industry insights, we examine the opportunities and challenges of AI-driven personalized medicine, from precision oncology and AI-powered drug discovery to biomarker identification, patient-specific therapies, and the integration of diverse health data to advance targeted treatment strategies.
- The issue also features The Biopharma Vanguard, spotlighting Chris Boerner’s leadership at Bristol Myers Squibb; AI Frontiers in Healthcare, showcasing Superluminal Medicines’ AI-native approach to molecular design and drug discovery; and Product Spotlight, highlighting Jardiance (empagliflozin) and its expanding role in cardiometabolic care.
